—Genetic loci that are associated with disability in multiple sclerosis have been identified as contributing to its progression, showing that the central nervous system, not the immune system, ...
The Epstein-Barr virus and a high-risk gene may work together to trick the immune system into attacking the brain in MS, a study suggests.
A genome-wide association study (GWAS) including more than 22,000 people with multiple sclerosis (MS) has uncovered the first genetic variant associated with faster progression of the autoimmune ...
“Our study shows how the most important environmental and genetic risk factors can contribute to MS and trigger an autoimmune response that targets myelin components in the brain,” he said. “Our ...
Prof Nicholas Schwab and his colleagues found a biomarker which allows to tell in advance if therapy with glatirameracetate will be efficient in an individual MS patent. Treatment with interferon or ...
Researchers have identified the first genetic marker of multiple sclerosis severity. The genetic variant was seen in people who experienced quicker progression of the disease, resulting in greater ...
“We knew that genetics is important for risk, but this variability of outcome suggested that genetics may also play a role in severity.” Dr. Baranzini and his team utilized data from two large MS ...
Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...
In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long considered the best way to monitor MS disease progression, may not be the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results